Your browser doesn't support javascript.
Endocrine Surgery Patients' and Providers' Perceptions of Telemedicine in the COVID Era.
Zheng, Hui; Rosen, Jennifer E; Bader, Nicholas A; Lai, Victoria.
  • Zheng H; Division of Endocrine Surgery, MedStar-Washington Hospital Center, Washington, District of Columbia 20010.
  • Rosen JE; Division of Endocrine Surgery, MedStar-Washington Hospital Center, Washington, District of Columbia 20010.
  • Bader NA; Georgetown University School of Medicine, Washington, District of Columbia 20007.
  • Lai V; Division of Endocrine Surgery, MedStar-Washington Hospital Center, Washington, District of Columbia 20010. Electronic address: Victoria.lai@medstar.net.
J Surg Res ; 269: 76-82, 2022 01.
Article in English | MEDLINE | ID: covidwho-1521354
ABSTRACT

BACKGROUND:

Telemedicine has become a key modality for health care delivery during the COVID-19 pandemic, including for endocrine surgery. Little data exists on patients' and referring endocrinologists' perspectives of its use. The study aimed to assess and compare endocrine surgery patients' attitudes about telemedicine to that of referring endocrinologists.

METHOD:

Patients from a regional endocrine surgery practice and referring endocrinologists were sent surveys about their perspectives on telemedicine use.

RESULTS:

Fifty two patients responded average age was 58.3 years; 78% were female; 33% were Black. Sixteen referring endocrinologists responded average age was 52.4 years; 62.5% were female. Nearly all patients (92%) and providers (100%) would try telemedicine or use it again. Providers were more likely than patients to use telemedicine because of COVID-19 (100% versus 70.6%, P = 0.03). Patients were more concerned about the lack of personal connection with telemedicine than providers (60.8% versus 25.0%, P = 0.02). Endocrinologists were more interested in using telemedicine to review abnormal results (81.3% versus 35.3%, P <0.01), and more patients were specifically disinterested in reviewing abnormal results via telemedicine (54.9% versus 6.3%, P = 0.04). Patients were more interested in its use for postoperative visits (47.1% versus 0%, P <0.01). More endocrinologists were specifically disinclined to conduct new consultations with telemedicine (87.5% versus 58.8%, P <0.01).

CONCLUSION:

Telemedicine is a mutually acceptable method for patients and their referring providers for endocrine surgery delivery, although in-person visits continue to have their place. Telemedicine use may continue to expand after the pandemic as an important point of access for endocrine surgery.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Endocrine Surgical Procedures / Telemedicine / Endocrinology / COVID-19 Type of study: Observational study / Prognostic study Limits: Female / Humans / Male / Middle aged Language: English Journal: J Surg Res Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Endocrine Surgical Procedures / Telemedicine / Endocrinology / COVID-19 Type of study: Observational study / Prognostic study Limits: Female / Humans / Male / Middle aged Language: English Journal: J Surg Res Year: 2022 Document Type: Article